ID
17379
Descripción
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms; ODM derived from: https://clinicaltrials.gov/show/NCT00082784
Link
https://clinicaltrials.gov/show/NCT00082784
Palabras clave
Versiones (1)
- 10/9/16 10/9/16 -
Subido en
10 de septiembre de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue NCT00082784
Eligibility Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue NCT00082784
- StudyEvent: Eligibility
Similar models
Eligibility Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue NCT00082784
- StudyEvent: Eligibility
C0023508 (UMLS CUI [2])
C1176309 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0281603 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3,1])
C0002144 (UMLS CUI [3,2])
C1527304 (UMLS CUI [4,1])
C0142915 (UMLS CUI [4,2])
C1527304 (UMLS CUI [5,1])
C0011777 (UMLS CUI [5,2])
C1516728 (UMLS CUI [2])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [1,2])
C0201836 (UMLS CUI [2])
C0373595 (UMLS CUI [2])